Latest

• Ventilatorassociated lower respiratory tract infections: etiology and diagnosis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(1):17-25

• Use of chlorhexidine for the prophylaxis of nosocomial infections in ICU

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):30-38

• Comparison of the qSOFA and NEWS scores and the SIRS criteria in predicting outcomes in emergency department patients with and without infection: results from a prospective observational study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):18-25

• The results of identification of bacteria from positive blood cultures using MALDI-TOF mass spectrometry

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):381-386

• The role of antimicrobial therapy stewardship in intensive care service

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(2):132-140

• Use of the Anti-Pseudomonas Vaccine for Prophylaxis and Treatment of Nosocomial Infections in Patients with Severe Burn Trauma

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(4):301-309

• Septic Arthritis in Adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(3):187-206

• Telavancin — New Antimicrobial Active Against Multiresistant Gram-Positive Pathogens. Clinical and Microbiological Features in Questions and Answers

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):127-145

• Clinical Guidelines on Diagnosis, Treatment and Prophylaxis of Severe Community-Acquired Pneumonia in Adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):84-126

• Infections in Russian ICUs: Results of the Nationwide Multicenter Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(4):294-303

• Nosocomial Meningitis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):149-157

• Surviving Sepsis Campaign 2008: Overview and Analysis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(3):192-200

• Comparative Predictive Value of the Severity Assessment Tools in ICU Patients with Community-Acquired Pneumonia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(4):330-336

• Assessment of Mortality Rate and Efficacy of Antimicrobial Therapy in Patients with Community-Acquired Pneumonia in Sverdlovsk Region

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(3):280-288

• Comparative Analysis of Etiology and Antimicrobial Resistance of the Main Nosocomial Pathogens Isolated from the ICUs in Ekaterinburg

  Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(4):410-418

• Corticosteroids in the Treatment of Septic Shock: the History is Going on

  Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(2):133-142

• Treatment of Sepsis in Intensive Care Units – Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(2):144-152

• Recommendations on the Optimization of Antimicrobial Chemotherapy of Nosocomial Infections Caused by GramdNegative Bacteria in Intensive Care Units (Guidelines for clinicians)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(4):379-390

• Ventilator-Associated Pneumonia: Debatable Questions in Terminology, Diagnostics and Empirical Antimicrobial Therapy

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(3):198-208

• Formulary of antimicrobials for intensive care units

  Clinical Microbiology and Antimicrobial Chemotherapy. 1999; 1(1):68-75